Dermatology - European Medical Journal

Continue

Dermatology

Filter
11 Mins
26 Nov 2019

IL-23 Inhibitors for Moderate-to-Severe Plaque Psoriasis: A Review of Clinical Efficacy, Safety, and Tolerability

Psoriasis is a common, chronic, immune-mediated skin disease affecting approximately 2–3% of the global population…
5 Mins
28 Oct 2019

Pathways to Silencing Psoriasis: Remission or Cure?

Psoriasis occurs more frequently alongside other IMID, indicating common pathogenetic pathways. Many of these IMID show familial accumulation…
4 Mins
18 Oct 2019

Advances and Latest Insights in Non-Biologic Systemic Therapeutic Agents in Psoriasis and Atopic Dermatitis

The fumarates, monoethyl fumarate (MEF) and dimethyl fumarate (DMF), are potent ester derivatives of fumaric acid. Fumaric acid esters (FAE)…
10 Mins
17 Sep 2019

IL-23 Inhibition in Psoriasis: A Novel Approach to Convenient, Consistent Clearance

This sponsored symposium took place on 12th June 2019 in Milan, Italy, as part of the 24th World Congress of Dermatology (WCD), 2019
9 Mins
16 Sep 2019

Spotlight on Acne

This symposium took place on 13th June 2019, as part of the World Congress of Dermatology (WCD) symposium in Milan, Italy
4 Mins
12 Sep 2019

Scalp Sarcoidosis with Systemic Involvement: A Case Report and Literature Review

Sarcoidosis is a multisystem disease, of unknown aetiology, which can involve any organ of the body, even if it more frequently affects the lymph nodes…
9 Mins
11 Sep 2019

IL-23 Inhibition as a Key Component in Psoriasis Treatment is Here to Stay

Prof Elke de Jong focussed her presentation on data from randomised clinical trials (RCT) and real-world evidence (RWE) from psoriasis patient registries.
10 Mins
20 Aug 2019

Right Treatment to the Right Patient in Moderate-to-Severe Psoriasis: Discussion on Difference

Dermatologists frequently see psoriasis patients for whom the most troublesome symptoms are not the constant physical discomfort…
We’ve noticed you’re accessing
from North/South America.